Hint mode is switched on Switch off

FTXH - First Trust Nasdaq Pharmaceuticals ETF (USD) (US33738R8372)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

Choose all Reset all
 
(%)
US33738R8372
FTXH ISIN
Exchange Traded Funds (ETF)
Type of fund
First Trust
Provider
34.53 USD
NAV per Share | 03/06/2026
20/09/2016
Inception Date
4 times per year
Dividend payments
CEOXMX
CFI
FTXH
Ticker
Formed
Status
Equity
Investment category
Healthcare
Sector
USA
Investor locations
Nasdaq US Smart Pharmaceuticals Index
Benchmark
0.6 %
Total Cost Ratio
34.53 mln USD
Fund NAV | 03/06/2026
34.53 mln USD
Share Class NAV | 03/06/2026
No
UCITS

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Yield on 03/06/2026, NASDAQ

  • YTD
    1.9 %
  • 1M
    -3.36 %
  • 3M
    -4.14 %
  • 6M
    6.24 %
  • 1Y
    35.3 %
  • 3Y
    33.95 %
  • 5Y
    36.59 %
  • 10Y
    -
At the price on the exchange, taking into account income payments

Latest data on
Add to compare
from
to
ADD-IN
Cbonds add-in API
bond data api

Quotes (FTXH)

Explore the most comprehensive database

1 000 000

bonds

80 234

stocks

167 970

ETF & Funds

70 000

indices

Track your portfolio in the most efficient way

  • Bond Search
  • Watchlist
  • Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 900 000 bonds, 80 000 stocks, 116 000 ETF & Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Price dynamics

FTXH profile

The First Trust Nasdaq Pharmaceuticals ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in USA. The First Trust fund’s base currency is USD and the share class was registered 20.09.2016 with unique ISIN - US33738R8372. Main exchange is NASDAQ and ticker symbol is FTXH. The total expense ratio is 0.6%. The First Trust Nasdaq Pharmaceuticals ETF (USD) pays dividends 4 time(s) per year.

Structure FTXH on 03/06/2026

Download structure in Excel
Paper Value
Eli Lilly and Company 7.73%
AbbVie Inc. 7.05%
Merck & Co., Inc. 6.98%
Johnson & Johnson 6.77%
Bristol-Myers Squibb Company 6.61%
Viatris Inc. 3.93%
Biogen Inc. 3.85%
Pfizer Inc. 3.45%
Amgen Inc. 3.28%
Gilead Sciences, Inc. 3.26%
Vertex Pharmaceuticals Incorporated 3.25%
Cardinal Health, Inc. 3.22%
United Therapeutics Corporation 3.05%
Regeneron Pharmaceuticals, Inc. 2.98%
Jazz Pharmaceuticals Plc 2.64%
Incyte Corporation 2.29%
Zoetis Inc. 2.23%
Illumina, Inc. 2.13%
Exelixis, Inc. 1.81%
Neurocrine Biosciences, Inc. 1.48%
Medpace Holdings, Inc. 1.33%
Charles River Laboratories International, Inc. 1.3%
PTC Therapeutics, Inc. 1.28%
Alkermes Plc 1.22%
Halozyme Therapeutics, Inc. 1.19%
BioMarin Pharmaceutical Inc. 1.18%
Elanco Animal Health Incorporated 0.92%
Spyre Therapeutics, Inc. 0.89%
Twist Bioscience Corporation 0.8%
Travere Therapeutics, Inc. 0.79%
10X Genomics, Inc. (Class A) 0.72%
Catalyst Pharmaceuticals, Inc. 0.7%
Guardant Health, Inc. 0.7%
TG Therapeutics, Inc. 0.69%
Arrowhead Pharmaceuticals, Inc. 0.65%
Arcus Biosciences, Inc. 0.61%
Ligand Pharmaceuticals Inc. (Class B) 0.61%
Amneal Pharmaceuticals, Inc. 0.57%
Krystal Biotech, Inc. 0.57%
Protagonist Therapeutics, Inc. 0.54%
Mirum Pharmaceuticals, Inc. 0.52%
Roivant Sciences Ltd. 0.51%
Ionis Pharmaceuticals, Inc. 0.47%
Moderna, Inc. 0.47%
Alnylam Pharmaceuticals, Inc. 0.46%
ACADIA Pharmaceuticals Inc. 0.45%
Kymera Therapeutics, Inc. 0.42%
Supernus Pharmaceuticals, Inc. 0.42%
Arcutis Biotherapeutics, Inc. 0.41%
Tarsus Pharmaceuticals, Inc. 0.4%
US Dollar 0.21%
Show more Hide
Other - %

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Other ETF & Funds from this provider

Similar ETF & Funds

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} mln
    NAV
    {{ item.expense_ratio }}
    Total Cost Ratio
Registration is required to get access.